The health authorization, published today (15) in the Federal Official Gazette, is valid for five years. Nunature enters the Brazilian market offering the product Cannabidiol Nunature in two different concentrations: 17.18 mg / ml and 34.36 mg / ml. The reduction in the concentration of CBD in the products is a market trend with the aim of reducing the commercialization price. The combination of organic farming practices with artisanal cannabis extraction is what sets us apart ”, says the company. In February, the pharmaceutical industry Prati-Donaduzzi received authorization from Anvisa to commercialize two new concentrations of its product Cannabidiol, which is already being marketed in 20 mg / ml and 50 mg / ml .
As soon as they are marketed in drugstores in the country, the new products now authorized by Anvisa will be the first to compete in retail windows with the Paraná company Prati-Donaduzzi, which since April last year has a health authorization to produce and sell Cannabidiol 200mg / ml
The National Health Surveillance Agency (Anvisa) authorized the production and commercialization in Brazil of two new products made from Cannabidiol (CBD), which is a cannabinoid derived from marijuana. The health authorization, published today (15) in the Federal Official Gazette, is valid for five years.
The new authorizations were granted from
Read the full article @ Cannabis Law Report